Physicochemical characterization of an aspin (rBm-33) from a filarial parasite Brugia malayi against the important human aspartic proteases

References

• Molyneux DH, Bradley M, Hoerauf A, Kyelem D, Taylor MJ. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol 2003;19:516–522.
   PubMed Web of Science ®Google Scholar
• Martzen MR, Geise GL, Hogan BJ, Peanasky RJ. Ascaris suum: localization by immunochemical and fluorescent probes of host proteases and parasite proteinase inhibitors in cross-sections. Exp Parasitol 1985;60:139–149.
   PubMedGoogle Scholar
• Peanasky RJ, Martzen MR, Homandberg GA, Cash JM, Babin, DR, Litweiler B. (1987). Molecular paradigms for eradicating helminthic parasites. New York: Alan R. Liss, 349–366.
   Google Scholar
• Craig C, Race E, Sheldon J, Whittaker L, Gilbert S, Moffatt A et al. HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapy. AIDS 1998;12:1611–1618.
   PubMed Web of Science ®Google Scholar
• Dame JB, Reddy GR, Yowell CA, Dunn BM, Kay J, Berry C. Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 1994;64:177–190.
   PubMedGoogle Scholar
• Monod M, Togni G, Hube B, Sanglard D. Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol Microbiol 1994;13:357–368.
   PubMed Web of Science ®Google Scholar
• Wlodawer A, Vondrasek J. Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. Annu Rev Biophys Biomol Struct 1998;27:249–284.
   PubMedGoogle Scholar
• Moon RP, Tyas L, Certa U, Rupp K, Bur D, Jacquet C et al. Expression and characterisation of plasmepsin I from Plasmodium falciparum. Eur J Biochem 1997;244:552–560.
   PubMedGoogle Scholar
• Roberts NA, Craig JC, Sheldon J. Resistance and cross-resistance with saquinavir and other HIV protease inhibitors: theory and practice. AIDS 1998;12:453–460.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Takahashi K, Kaneko T, Ogasawara H, Shindo S, Kobayashi M. Human renin-binding protein is the enzyme N-acetyl-D-glucosamine 2-epimerase. J Biochem 1999;125:348–353.
   PubMedGoogle Scholar
• Kreft S, Ravnikar M, Mesko P, Pungercar J, Umek A, Kregar I et al. Jasmonic acid inducible aspartic proteinase inhibitors from potato. Phytochemistry 1997;44:1001–1006.
   PubMedGoogle Scholar
• Christeller JT, Farley PC, Ramsay RJ, Sullivan PA, Laing WA. Purification, characterization and cloning of an aspartic proteinase inhibitor from squash phloem exudate. Eur J Biochem 1998;254:160–167.
   PubMedGoogle Scholar
• Saheki T, Matsuda Y, Holzer H. Urification and characterization of macromolecular inhibitors of proteinase A from yeast. Eur J Biochem 1974;47:325–332.
   PubMedGoogle Scholar
• Abu-Erreish GM, Peanasky RJ. Pepsin inhibitors from Ascaris lumbricoides. Isolation, purification, and some properties. J Biol Chem 1974;249:1558–1565.
   PubMedGoogle Scholar
• Petersen W, Cherney MM, Garen C, Zalatoris JJ, Rao-Naik C, Dunn BM et al. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3. Nat Struct Biol 2000;7:653–657.
   PubMedGoogle Scholar
• Dissanayake S, Xu M, Nkenfou C, Piessens WF. Molecular cloning and serological characterization of a Brugia malayi pepsin inhibitor homolog. Mol Biochem Parasitol 1993;62:143–146.
   PubMedGoogle Scholar
• Krushna NS, Shiny C, Dharanya S, Sindhu A, Aishwarya S, Narayanan RB. Immunolocalization and serum antibody responses to Brugia malayi pepsin inhibitor homolog (Bm-33). Microbiol Immunol 2009;53:173–183.
   PubMedGoogle Scholar
• Krushna NS, Shiny C, Manokaran G, Elango S, Babu S, Narayanan RB. Immune responses to recombinant Brugia malayi pepsin inhibitor homolog (Bm-33) in patients with human lymphatic filariaisis. Parasitol Res 2011;108:407–415.
   PubMedGoogle Scholar
• Krishna NR, Krushna NS, Narayanan RB, Rajan SS, Gunasekaran K. Expression, purification and characterization of refolded rBm-33 (pepsin inhibitor homolog) from Brugia malayi: a human Lymphatic Filarial parasite. Protein Expr Purif 2011;79:245–250.
   PubMedGoogle Scholar
• Takahashi K. (1995). Aspartic proteinases: structure, function, biology and biomedical implications. New York: Plenum Press, 581–587.
   Google Scholar
• Kornfeld S, Mellman I. The biogenesis of lysosomes. Annu Rev Cell Biol 1989;5:483–525.
   PubMedGoogle Scholar
• von Figura K, Hasilik A. Lysosomal enzymes and their receptors. Annu Rev Biochem 1986;55:167–193.
   PubMed Web of Science ®Google Scholar
• Lapresle C, Barrett AJ, Dingle J. (1971). Tissue proteinases. Amsterdam: North-Holland Publishing Co, 135–155.
   Google Scholar
• Barrett AJ. (1977). Proteinases in mammalian cells and tissues. Amsterdam: Elsevier/North-Holland Bio-medical Press, 209–248.
   Google Scholar
• Kageyama T, Ichinose M, Tsukada S, Miki K, Kurokawa K, Koiwai O et al. Gastric procathepsin E and progastricsin from guinea pig. Purification, molecular cloning of cDNAs, and characterization of enzymatic properties, with special reference to procathepsin E. J Biol Chem 1992;267:16450–16459.
   PubMedGoogle Scholar
• Perez-Iratxeta C, Andrade-Navarro MA. K2D2: estimation of protein secondary structure from circular dichroism spectra. BMC Struct Biol 2008;8:25.
   PubMed Web of Science ®Google Scholar
• Anson ML. The estimation of pepsin, trypsin, papain, and cathepsin with hemoglobin. J Gen Physiol 1938;22:79–89.
   PubMed Web of Science ®Google Scholar
• Wiseman T, Williston S, Brandts JF, Lin LN. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal Biochem 1989;179:131–137.
   PubMed Web of Science ®Google Scholar
• ITC data analysis in Origin”, Tutorial guide 7.0, Microcal#. Northampton, MA, 2002, 99.
   Google Scholar
• Wetzel R, Perry LJ, Baase WA, Becktel WJ. Disulfide bonds and thermal stability in T4 lysozyme. Proc Natl Acad Sci USA 1988;85:401–405.
   PubMedGoogle Scholar
• Kageyama T. Molecular cloning, expression and characterization of an Ascaris inhibitor for pepsin and cathepsin E. Eur J Biochem 1998;253:804–809.
   PubMedGoogle Scholar
• Rich DH, Sun ET. Mechanism of inhibition of pepsin by pepstatin. Effect of inhibitor structure on dissociation constant and time-dependent inhibition. Biochem Pharmacol 1980;29:2205–2212.
   PubMed Web of Science ®Google Scholar
• Bennett K, Levine T, Ellis JS, Peanasky RJ, Samloff IM, Kay J et al. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur J Immunol 1992;22:1519–1524.
   PubMed Web of Science ®Google Scholar
• Kageyama T, Yonezawa S, Ichinose M, Miki K, Moriyama A. Potential sites for processing of the human invariant chain by cathepsins D and E. Biochem Biophys Res Commun 1996;223:549–553.
   PubMedGoogle Scholar
• Imai T, Miyazaki H, Hirose S, Hori H, Hayashi T, Kageyama R et al. Cloning and sequence analysis of cDNA for human renin precursor. Proc Natl Acad Sci USA 1983;80:7405–7409.
   PubMed Web of Science ®Google Scholar
• Ohnshi H. Pepsin-immunoregulation hypothesis. Med Hypotheses 1984;13:189-198.
   PubMedGoogle Scholar
• Ohnshi H. Pepsin like enzyme in macrophages and its role in the immune system. Clin Exp Immunol 1984;58:206–212.
   PubMedGoogle Scholar